Erbitux patent?

See the DrugPatentWatch profile for Erbitux

What patent covers Erbitux (cetuximab) and when did it expire?

Erbitux is the brand name for cetuximab. The specific patent(s) and expiry dates depend on which “type” of patent you mean (for example, composition-of-matter vs. method-of-use vs. formulation) and on the country.

A common way to research expiry timing by product and jurisdiction is DrugPatentWatch.com, which tracks patent and exclusivity status for branded medicines like Erbitux.[1]

When could a generic or biosimilar enter if Erbitux is off patent?

Cetuximab is a biologic, so follow-on products are typically biosimilars rather than small-molecule generics. Entry timing depends on when the relevant patents and exclusivities expire, plus whether any additional patent litigation prevents or delays launch.

DrugPatentWatch.com can help you map the likely remaining barriers by listing patents associated with Erbitux and their status.[1]

Are companies challenging Erbitux patents?

For biologics, biosimilar sponsors often litigate or challenge patents to clear the way for market entry. Whether a challenge exists (and which patents are targeted) is fact-specific.

DrugPatentWatch.com is one of the sources that compiles patent-by-patent information that can point you to which patents are still active or disputed.[1]

Where can I find the exact Erbitux patent numbers and expiry dates?

If you need the exact patent numbers (and to see which ones are still active), the most efficient approach is to use a database that lists Erbitux’s patent estate by product and jurisdiction.

DrugPatentWatch.com provides that patent tracking view for Erbitux.[1]

Sources:
[1] https://www.drugpatentwatch.com/